Aerosol Delivery Devices Market PPT: Trends and Dynamics, Drivers, Competitive landscape and Future Opportunities 2032

1
Global Aerosol Delivery Devices Market Research
and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Aerosol Delivery Devices Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the global aerosol
  delivery devices market size reached US 47.1
  Billion in 2023.
• Aerosol delivery devices refer to an advanced
  method of drug administration wherein a drug is
  directly delivered to the lungs for a systemic
  effect. Some commonly used aerosol delivery
  devices include pressurized metered-dose
  inhalers, nebulizers, and valved holder chambers.
  They are generally used as rescue therapy or
  permanent treatment for various respiratory
  disorders, such as asthma, obstructive lung
  diseases, cystic fibrosis (CF), pulmonary
  arterial hypertension, and infectious pulmonary.
• They are also utilized in treating
  non-respiratory conditions, including diabetes,
  analgesia, thyroid disorders, and genetic
  diseases. They aid in lowering the dosage
  requirements, minimizing systemic adverse
  effects, and improving the ability of patients to
  self-administer medications. As a result, aerosol
  delivery devices find extensive applications in
  drug delivery and treatment of various medical
  conditions.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/aerosol-delivery-device
  s-market/requestsample

4
Report Description

• Global Aerosol Delivery Devices Market Trends
• The rising incidences of chronic respiratory
  diseases due to surging air pollution levels,
  allergens, occupational risks, and unhealthy
  habits like smoking represent the primary factor
  driving the market growth. Moreover, the sudden
  coronavirus disease (COVID-19) outbreak that
  causes acute respiratory infections among
  patients is another major growth-inducing factor.
  In addition, there has been widespread adoption
  of aerosol delivery devices in treating
  obstructive airway diseases at home and in
  healthcare settings. Along with this, the
  expanding geriatric population that is more
  susceptible to developing critical health
  conditions has augmented the product demand.
  Besides this, the increasing preferences for
  personalized drug therapy coupled with the advent
  of novel macromolecular medications have
  propelled market growth. Furthermore, the leading
  manufacturers are introducing innovative product
  variants that assist in treating chronic
  inflammation and infection in the lungs and
  improve airway clearance in patients with CF. In
  line with this, the development of convenient,
  economical, and portable inhalation devices has
  accelerated product adoption rates. Apart from
  this, the rising usage of e-commerce channels for
  purchasing medical supplies and the availability
  of mini ultrasonic nebulizers and inhalers that
  have automatic memory and are easy to use while
  traveling are providing a positive thrust to the
  market growth.
• Looking forward, the market value to reach US
  73.4 Billion by 2032, expanding at a CAGR of 4.9
  during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/aerosol-delivery-device
  s-market

5
Report Segmentation

• Breakup by Product
• Dry Powder Inhalers
• Single Dose Inhalers
• Multi Dose Inhalers
• Metered Dose Inhalers
• Conventional Pressurized Inhalers
• Soft Mist Inhalers 
• Nebulizers
• Jet Nebulizers
• Ultrasonic Wave Nebulizers
• Vibrating Mesh Nebulizers
• Breakup by Application
• Asthma

6
Report Segmentation

• Chronic Obstructive Pulmonary Disease (COPD)
• Cystic Fibrosis
• Non-Respiratory Diseases
• Diabetes
• Analgesia
• Parkinsons Disease
• Breakup by Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online Stores

7
Report Segmentation

• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

8
Competitive Landscape with Key Players

• 3M Company
• Aerogen
• GlaxoSmithKline plc
• Johnson Johnson
• Koninklijke Philips N.V.
• Merck Co. Inc.
• Metall Zug AG
• Recipharm AB (publ)
• Teva Pharmaceutical Industries Ltd.
• Vectura Group plc.

9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Aerosol Delivery
  Devices Market    5.1    Market Overview    5.2
     Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product
• 6.1 Dry Powder Inhalers
• 6.1.1 Market Trends
• 6.1.2 Key Segments
• 6.1.2.1 Single Dose Inhalers
• 6.1.2.2 Multi Dose Inhalers
• 6.1.3 Market Forecast
• 6.2 Metered Dose Inhalers
• 6.2.1 Market Trends
• 6.2.2 Key Segments       

11
Table of Contents

• 6.2.2.1 Conventional Pressurized
  Inhalers
• 6.2.2.2 Soft Mist Inhalers
• 6.2.3 Market Forecast
• 6.3 Nebulizers
• 6.3.1 Market Trends
• 6.3.2 Key Segments
• 6.3.2.1 Jet Nebulizers
• 6.3.2.2 Ultrasonic Wave Nebulizers
• 6.3.2.3 Vibrating Mesh Nebulizers
• 6.3.3 Market Forecast
• 7 Market Breakup by Application
• 7.1 Asthma
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Chronic Obstructive Pulmonary Disease
  (COPD)
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Cystic Fibrosis
• 7.3.1 Market Trends

12
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

13
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com